

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001237"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001237" />

    <meta name="citation_title" content="Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice"/>
    <meta itemprop="name" content="Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice"/>

      <meta name="citation_author" content="Tsai-Ling Lu"/>
            <meta name="citation_author_institution" content="Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan"/>
      <meta name="citation_author" content="Junn-Liang Chang"/>
            <meta name="citation_author_institution" content="Department of Pathology, Taoyuan Armed Forces General Hospital, Lungtan, Taoyuan County, Taiwan"/>
      <meta name="citation_author" content="Chih-Chia Liang"/>
            <meta name="citation_author_institution" content="Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan"/>
      <meta name="citation_author" content="Li-Ru You"/>
            <meta name="citation_author_institution" content="Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan"/>
      <meta name="citation_author" content="Chun-Ming Chen"/>
            <meta name="citation_author_institution" content="Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan"/>

    <meta name="citation_date" content="2007/11/28"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001237.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1237"/>
    <meta name="citation_issue" content="11"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.; citation_author=V Stambolic; citation_author=A Suzuki; citation_author=JL de la Pompa; citation_author=GM Brothers; citation_author=C Mirtsos; citation_journal_title=Cell; citation_volume=95; citation_number=1; citation_pages=29-39; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.; citation_author=X Wu; citation_author=K Senechal; citation_author=MS Neshat; citation_author=YE Whang; citation_author=CL Sawyers; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=95; citation_number=2; citation_pages=15587-15591; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=PTEN: a tumour suppressor that functions as a phospholipid phosphatase.; citation_author=T Maehama; citation_author=JE Dixon; citation_journal_title=Trends Cell Biol; citation_volume=9; citation_number=3; citation_pages=125-128; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.; citation_author=M Cully; citation_author=H You; citation_author=AJ Levine; citation_author=TW Mak; citation_journal_title=Nat Rev Cancer; citation_volume=6; citation_number=4; citation_pages=184-192; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.; citation_author=PA Steck; citation_author=MA Pershouse; citation_author=SA Jasser; citation_author=WK Yung; citation_author=H Lin; citation_journal_title=Nat Genet; citation_volume=15; citation_number=5; citation_pages=356-362; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.; citation_author=J Li; citation_author=C Yen; citation_author=D Liaw; citation_author=K Podsypanina; citation_author=S Bose; citation_journal_title=Science; citation_volume=275; citation_number=6; citation_pages=1943-1947; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.; citation_author=DH Teng; citation_author=R Hu; citation_author=H Lin; citation_author=T Davis; citation_author=D Iliev; citation_journal_title=Cancer Res; citation_volume=57; citation_number=7; citation_pages=5221-5225; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Pten is essential for embryonic development and tumour suppression.; citation_author=A Di Cristofano; citation_author=B Pesce; citation_author=C Cordon-Cardo; citation_author=PP Pandolfi; citation_journal_title=Nat Genet; citation_volume=19; citation_number=8; citation_pages=348-355; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice.; citation_author=V Stambolic; citation_author=MS Tsao; citation_author=D Macpherson; citation_author=A Suzuki; citation_author=WB Chapman; citation_journal_title=Cancer Res; citation_volume=60; citation_number=9; citation_pages=3605-3611; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.; citation_author=H Sun; citation_author=R Lesche; citation_author=DM Li; citation_author=J Liliental; citation_author=H Zhang; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=96; citation_number=10; citation_pages=6199-6204; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.; citation_author=A Suzuki; citation_author=JL de la Pompa; citation_author=V Stambolic; citation_author=AJ Elia; citation_author=T Sasaki; citation_journal_title=Curr Biol; citation_volume=8; citation_number=11; citation_pages=1169-1178; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.; citation_author=K Podsypanina; citation_author=LH Ellenson; citation_author=A Nemes; citation_author=J Gu; citation_author=M Tamura; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=96; citation_number=12; citation_pages=1563-1568; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.; citation_author=MJ Kim; citation_author=RD Cardiff; citation_author=N Desai; citation_author=WA Banach-Petrosky; citation_author=R Parsons; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=99; citation_number=13; citation_pages=2884-2889; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.; citation_author=Z Chen; citation_author=LC Trotman; citation_author=D Shaffer; citation_author=HK Lin; citation_author=ZA Dotan; citation_journal_title=Nature; citation_volume=436; citation_number=14; citation_pages=725-730; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.; citation_author=DJ Freeman; citation_author=AG Li; citation_author=G Wei; citation_author=HH Li; citation_author=N Kertesz; citation_journal_title=Cancer Cell; citation_volume=3; citation_number=15; citation_pages=117-130; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.; citation_author=C Abate-Shen; citation_author=WA Banach-Petrosky; citation_author=X Sun; citation_author=KD Economides; citation_author=N Desai; citation_journal_title=Cancer Res; citation_volume=63; citation_number=16; citation_pages=3886-3890; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.; citation_author=A Di Cristofano; citation_author=M De Acetis; citation_author=A Koff; citation_author=C Cordon-Cardo; citation_author=PP Pandolfi; citation_journal_title=Nat Genet; citation_volume=27; citation_number=17; citation_pages=222-224; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Conditional alleles in mice: practical considerations for tissue-specific knockouts.; citation_author=KM Kwan; citation_journal_title=Genesis; citation_volume=32; citation_number=18; citation_pages=49-62; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Site- and time-specific gene targeting in the mouse.; citation_author=D Metzger; citation_author=P Chambon; citation_journal_title=Methods; citation_volume=24; citation_number=19; citation_pages=71-80; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.; citation_author=S Wang; citation_author=J Gao; citation_author=Q Lei; citation_author=N Rozengurt; citation_author=C Pritchard; citation_journal_title=Cancer Cell; citation_volume=4; citation_number=20; citation_pages=209-221; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.; citation_author=X Ma; citation_author=AC Ziel-van der Made; citation_author=B Autar; citation_author=HA van der Korput; citation_author=M Vermeij; citation_journal_title=Cancer Res; citation_volume=65; citation_number=21; citation_pages=5730-5739; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten.; citation_author=SA Backman; citation_author=D Ghazarian; citation_author=K So; citation_author=O Sanchez; citation_author=KU Wagner; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=101; citation_number=22; citation_pages=1725-1730; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Pten dose dictates cancer progression in the prostate.; citation_author=LC Trotman; citation_author=M Niki; citation_author=ZA Dotan; citation_author=JA Koutcher; citation_author=A Di Cristofano; citation_journal_title=PLoS Biol; citation_volume=1; citation_number=23; citation_pages=E59; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.; citation_author=OH Yilmaz; citation_author=R Valdez; citation_author=BK Theisen; citation_author=W Guo; citation_author=DO Ferguson; citation_journal_title=Nature; citation_volume=441; citation_number=24; citation_pages=475-482; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.; citation_author=S Wang; citation_author=AJ Garcia; citation_author=M Wu; citation_author=DA Lawson; citation_author=ON Witte; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=103; citation_number=25; citation_pages=1480-1485; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=PTEN-deficient intestinal stem cells initiate intestinal polyposis.; citation_author=XC He; citation_author=T Yin; citation_author=JC Grindley; citation_author=Q Tian; citation_author=T Sato; citation_journal_title=Nat Genet; citation_volume=39; citation_number=26; citation_pages=189-198; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.; citation_author=TC Badea; citation_author=Y Wang; citation_author=J Nathans; citation_journal_title=J Neurosci; citation_volume=23; citation_number=27; citation_pages=2314-2322; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.; citation_author=R Lesche; citation_author=M Groszer; citation_author=J Gao; citation_author=Y Wang; citation_author=A Messing; citation_journal_title=Genesis; citation_volume=32; citation_number=28; citation_pages=148-149; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.; citation_author=M Groszer; citation_author=R Erickson; citation_author=DD Scripture-Adams; citation_author=R Lesche; citation_author=A Trumpp; citation_journal_title=Science; citation_volume=294; citation_number=29; citation_pages=2186-2189; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=PTEN gene alterations in lymphoid neoplasms.; citation_author=A Sakai; citation_author=C Thieblemont; citation_author=A Wellmann; citation_author=ES Jaffe; citation_author=M Raffeld; citation_journal_title=Blood; citation_volume=92; citation_number=30; citation_pages=3410-3415; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.; citation_author=P Cairns; citation_author=K Okami; citation_author=S Halachmi; citation_author=N Halachmi; citation_author=M Esteller; citation_journal_title=Cancer Res; citation_volume=57; citation_number=31; citation_pages=4997-5000; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=PTEN/MMAC1 mutations in endometrial cancers.; citation_author=JI Risinger; citation_author=AK Hayes; citation_author=A Berchuck; citation_author=JC Barrett; citation_journal_title=Cancer Res; citation_volume=57; citation_number=32; citation_pages=4736-4738; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.; citation_author=DJ Marsh; citation_author=V Coulon; citation_author=KL Lunetta; citation_author=P Rocca-Serra; citation_author=PL Dahia; citation_journal_title=Hum Mol Genet; citation_volume=7; citation_number=33; citation_pages=507-515; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=The biology and clinical relevance of the PTEN tumor suppressor pathway.; citation_author=I Sansal; citation_author=WR Sellers; citation_journal_title=J Clin Oncol; citation_volume=22; citation_number=34; citation_pages=2954-2963; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Will the real Cowden syndrome please stand up: revised diagnostic criteria.; citation_author=C Eng; citation_journal_title=J Med Genet; citation_volume=37; citation_number=35; citation_pages=828-830; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Genetic background controls tumor development in PTEN-deficient mice.; citation_author=D Freeman; citation_author=R Lesche; citation_author=N Kertesz; citation_author=S Wang; citation_author=G Li; citation_journal_title=Cancer Res; citation_volume=66; citation_number=36; citation_pages=6492-6496; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).; citation_author=L Hu; citation_author=C Zaloudek; citation_author=GB Mills; citation_author=J Gray; citation_author=RB Jaffe; citation_journal_title=Clin Cancer Res; citation_volume=6; citation_number=37; citation_pages=880-886; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Inhibition of the phosphatidylinositol 3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo.; citation_author=VM Bondar; citation_author=B Sweeney-Gotsch; citation_author=M Andreeff; citation_author=GB Mills; citation_author=DJ McConkey; citation_journal_title=Mol Cancer Ther; citation_volume=1; citation_number=38; citation_pages=989-997; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.; citation_author=S Shukla; citation_author=GT Maclennan; citation_author=DJ Hartman; citation_author=P Fu; citation_author=MI Resnick; citation_journal_title=Int J Cancer; citation_volume=121; citation_number=39; citation_pages=1424-1432; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.; citation_author=CH Kwon; citation_author=X Zhu; citation_author=J Zhang; citation_author=SJ Baker; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=100; citation_number=40; citation_pages=12923-12928; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.; citation_author=MR Milam; citation_author=J Celestino; citation_author=W Wu; citation_author=RR Broaddus; citation_author=KM Schmeler; citation_journal_title=Am J Obstet Gynecol; citation_volume=196; citation_number=41; citation_pages=247 e241-245; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice.; citation_author=X Mao; citation_author=Y Fujiwara; citation_author=SH Orkin; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=96; citation_number=42; citation_pages=5037-5042; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.; citation_author=CM Chen; citation_author=RR Behringer; citation_journal_title=Genes Dev; citation_volume=18; citation_number=43; citation_pages=320-332; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.; citation_author=CM Chen; citation_author=JL Chang; citation_author=RR Behringer; citation_journal_title=Oncogene; citation_volume=23; citation_number=44; citation_pages=7722-7725; citation_date=2004; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice"/>
    <meta name="twitter:description" content="BackgroundPten functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of Pten gene in mice has elucidated the role of Pten in different tumor progression models. However, a temporally controlled Pten loss in all adult tissues to examine susceptibility of various tissues to Pten-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse.Methods and FindingsWe utilized an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of ROSA26 (R26)-CreERT;Ptenfx/fx mice. On reaching 45 weeks 4OHT-induced Pten loss, we found that the R26-CreERT;Ptenfx/fx mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the Pten-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10&sim;11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on Pten-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced Pten loss was significantly suppressed by LY294002 (p&#8202;=&#8202;0.007).ConclusionsThrough monitoring a variety of Pten-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised. Therefore, this R26-CreERT; Ptenfx/fx mouse model may provide an entry point for understanding the role of Pten in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent Pten-deficient malignancies."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001237.g008"/>

  <meta property="og:title" content="Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=7017'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=3310'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=2963&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001237">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001237" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001237&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Tumor Spectrum, Tumor Latency and Tumor Incidence of the <i>Pten</i>-Deficient Mice
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Tsai-Ling Lu
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Tsai-Ling Lu, Junn-Liang Chang</p>

              
              

                <p>Affiliation:
                  Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Junn-Liang Chang
              <span class="equal-contrib"
                    title="These authors contributed equally to this work">equal contributor</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">

                <p><span class="equal-contrib" title="These authors contributed equally to this work">equal contributor</span>
                Contributed equally to this work with: Tsai-Ling Lu, Junn-Liang Chang</p>

              
              

                <p>Affiliation:
                  Department of Pathology, Taoyuan Armed Forces General Hospital, Lungtan, Taoyuan County, Taiwan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chih-Chia Liang, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Li-Ru You, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chun-Ming Chen
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:cmchen@ym.edu.tw">cmchen@ym.edu.tw</a></p>

                <p>Affiliation:
                  Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei, Taiwan
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: November 28, 2007</li>
    <li>DOI: 10.1371/journal.pone.0001237</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001237-g001" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g002" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g003" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-t001" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g004" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g005" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g006" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g007" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g007" title="Figure 7">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g007&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001237-g008" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g008" title="Figure 8">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g008&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001237">Reader Comments (2)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001237" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p><em>Pten</em> functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of <em>Pten</em> gene in mice has elucidated the role of <em>Pten</em> in different tumor progression models. However, a temporally controlled <em>Pten</em> loss in all adult tissues to examine susceptibility of various tissues to <em>Pten</em>-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of <em>Pten</em>-deficient malignancies in multiple tissue lineages of the adult mouse.</p>


<h3>Methods and Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>We utilized an inducible Cre/<em>lox</em>P system to delete <em>Pten exon 5</em> in the systemic organs of <em>ROSA26 (R26)-CreER<sup>T</sup>;Pten<sup>fx/fx</sup></em> mice. On reaching 45 weeks 4OHT-induced <em>Pten</em> loss, we found that the <em>R26-CreER<sup>T</sup>;Pten<sup>fx/fx</sup></em> mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the <em>Pten</em>-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10~11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on <em>Pten</em>-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced <em>Pten</em> loss was significantly suppressed by LY294002 (<em>p</em> = 0.007).</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>Through monitoring a variety of <em>Pten</em>-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the <em>Pten</em> gene is excised. Therefore, this <em>R26-CreER<sup>T</sup>; Pten<sup>fx/fx</sup></em> mouse model may provide an entry point for understanding the role of <em>Pten</em> in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent <em>Pten</em>-deficient malignancies.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Lu T-L, Chang J-L, Liang C-C, You L-R, Chen C-M (2007) Tumor Spectrum, Tumor Latency and Tumor Incidence of the <em>Pten</em>-Deficient Mice. PLoS ONE 2(11):
          e1237.
            doi:10.1371/journal.pone.0001237</p><p><strong>Academic Editor: </strong>Dong-Yan Jin, University of Hong Kong, China</p><p><strong>Received:</strong> August 6, 2007; <strong>Accepted:</strong> November 1, 2007; <strong>Published:</strong> November 28, 2007</p><p><strong>Copyright:</strong> © 2007 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>Supported by the Ministry of Education, Aim for the Top University Plan and the National Science Council, Taiwan, (NSC 95-2320-B-010-004, NSC 95-2320-B-010-014 and NSC 96-3112-B-010-016) to C-MC. Supported by the Research Foundation of Taoyuan Armed Forces General Hospital (9519 and 9612) to J-LC.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Tumors occur in normal tissues that are challenged by a variety of genetic and environmental risk factors. These risk factors may consequently evoke aberrant effects on cytoplasmic signaling network, which result in uncontrolled cellular proliferation, cell survival and heterotypic cross-talk with neighboring cells. Among the various types of complicated cellular signaling circuitry that have been identified, the tumor suppressor <em>PTEN</em>, a phosphatase and tension homolog on chromosome 10, acts as the most important negative regulator of the phosphatidylinositol 3-kinase (PI-3K) signaling pathway <a href="#pone.0001237-Stambolic1">[1]</a>, <a href="#pone.0001237-Wu1">[2]</a>. PTEN converts PIP3 to phosphatidylinositol (4,5) diphosphate (PIP2) in order to maintain a homeostasis of PIP3, which is generated by PI-3K activation <a href="#pone.0001237-Maehama1">[3]</a>. Inactivation of PTEN results in an accumulation of PIP3, which recruits the serine/threonine kinase PKB/AKT to the cell membrane and this further activate downstream of the PI-3K/AKT signaling pathway to promote cellular proliferation, anti-apoptosis, cell survival and tumorigenesis <a href="#pone.0001237-Stambolic1">[1]</a>, <a href="#pone.0001237-Cully1">[4]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Mutation of <em>PTEN</em> is often seen in human cancers <a href="#pone.0001237-Steck1">[5]</a>, <a href="#pone.0001237-Li1">[6]</a>, <a href="#pone.0001237-Teng1">[7]</a>. Using a gene targeting strategy to ablate <em>Pten</em> gene function in the mouse causes embryonic lethality between days 6.5 to 9.5 of gestation <a href="#pone.0001237-DiCristofano1">[8]</a>, <a href="#pone.0001237-Stambolic2">[9]</a>, <a href="#pone.0001237-Sun1">[10]</a>, <a href="#pone.0001237-Suzuki1">[11]</a>. The early lethality of <em>Pten</em>-deficient mice limits our understanding regarding how PTEN regulates downstream signaling and is related to tumorigenesis at adult stage. Up to this point, mice heterozygous for <em>Pten</em> have provided some basis for study because they develop a variety of cancers, including breast cancer, endometrial cancer, prostate tumors and lymphoma <a href="#pone.0001237-DiCristofano1">[8]</a>, <a href="#pone.0001237-Stambolic2">[9]</a>, <a href="#pone.0001237-Suzuki1">[11]</a>, <a href="#pone.0001237-Podsypanina1">[12]</a>. Loss-of-heterozygosity of <em>Pten</em> might contribute to the tumor development in <em>Pten<sup>+/−</sup></em> mice<a href="#pone.0001237-Stambolic2">[9]</a>, <a href="#pone.0001237-Suzuki1">[11]</a>, <a href="#pone.0001237-Podsypanina1">[12]</a>. In addition, other genetic lesions such as <em>Nkx3.1</em>, <em>Trp53</em> or <em>p27KIP1</em> might be involved in decreasing latency and increasing invasiveness/metastasis during tumor development in <em>Pten<sup>+/−</sup></em> mice <a href="#pone.0001237-Kim1">[13]</a>, <a href="#pone.0001237-Chen1">[14]</a>, <a href="#pone.0001237-Freeman1">[15]</a>, <a href="#pone.0001237-AbateShen1">[16]</a>, <a href="#pone.0001237-DiCristofano2">[17]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Using Cre-loxP conditional genetics <a href="#pone.0001237-Kwan1">[18]</a>, <a href="#pone.0001237-Metzger1">[19]</a>, tissue-specific inactivation of <em>Pten</em> results in tumor formation in the targeted tissues of the mouse. Prostate-specific ablation of <em>lox</em>P-flanked <em>Pten</em> gene (<em>Pten<sup>fx/fx</sup></em>) utilizing different Cre transgenic mice lines such as probasin-Cre, prostate-specific antigen (PSA)-Cre or mouse mammary tumor virus (MMTV)-Cre has shown the occurrence of prostate cancer progression similar to that which occurs in humans <a href="#pone.0001237-Wang1">[20]</a>, <a href="#pone.0001237-Ma1">[21]</a>, <a href="#pone.0001237-Backman1">[22]</a>, <a href="#pone.0001237-Trotman1">[23]</a>. Likewise, conditionally ablating the <em>Pten</em> gene in hematopoietic lineages causes various leukemias in the mouse <a href="#pone.0001237-Yilmaz1">[24]</a>. Such Cre activity might also be present in the disease-initiating stem cells from which the <em>Pten</em> gene is deleted, which is followed by tumor initiation, expansion and progression <a href="#pone.0001237-Yilmaz1">[24]</a>, <a href="#pone.0001237-Wang2">[25]</a>, <a href="#pone.0001237-He1">[26]</a>. Thus, tissue-specific and cell type-specific <em>Pten</em> knockout mice have provided a fundamental basis for an understanding of the role of <em>Pten</em> in different tumor progression models. However, somatic inactivation of <em>Pten</em> in a temporally controlled manner in all adult tissues to test susceptibility of various tissues to <em>Pten</em>-deficient tumorigenesis has not been carried out up to the present.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>To assess the tumor incidence, latency and spectrum of <em>Pten</em>-deficient adult mice, we utilize two mouse strains: firstly, the <em>ROSA26 Cre-estrogen receptor (R26-CreER<sup>T</sup>)</em> knock-in mouse line, which expresses inducible Cre recombinase driven by the ubiquitous promoter <em>ROSA26</em> <a href="#pone.0001237-Badea1">[27]</a> and secondly, the <em>Pten<sup>fx/fx</sup></em> mouse carrying <em>lox</em>P-flanked exon 5 encoding the phosphatase domain of PTEN <a href="#pone.0001237-Lesche1">[28]</a>, <a href="#pone.0001237-Groszer1">[29]</a>. 4-hydroxytamoxifen (4-OHT) is administrated to induce the <em>Pten</em> gene excision in a temporally controlled manner in the crossed mutant offspring (<em>R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></em>). In this report, we found that lymphoid lineages, the squamous epithelium of the epidermis, the simple epithelium of the prostate, the endometrium and the intestine are highly susceptible to tumorigenesis in such a <em>Pten</em>-deficient background. Application of the PI3K inhibitor LY294002 in these <em>Pten</em>-deficient mice resulted in the enlargement of the anterior prostate glands being significantly suppressed. Thus, we have established a <em>Pten</em>-deficient tumor model, which demonstrates that multiple cell lineages can be provoked to undergo aberrant cellular signaling simultaneously and that this results in major changes of normal tissues.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>Temporally controlled CreER-mediated recombination by 4OHT administration</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>The inducible Cre activity of the <em>R26-CreER<sup>T</sup></em> transgenic mice was demonstrated in neuronal tissues by Badea et al. <a href="#pone.0001237-Badea1">[27]</a>. In this report, we have examined temporally controlled Cre activity in the systemic organs of <em>R26-CreER<sup>T</sup>; R26R</em> bigenic mice. After 4OHT treatment for one week, whole mount X-gal staining revealed that the 4OHT-induced β-galactosidase expression showed focal or mosaic blue patterns in the brain, liver, pancreas, kidney, intestine, uterus and bladder of <em>R26-CreER<sup>T</sup>;R26R</em> bigenic males or females (<a href="#pone-0001237-g001"><strong>Figure 1</strong></a>). Non-specific X-gal staining was also observed in the hind-stomach, the gut, the prostate and the vas deferens (<a href="#pone-0001237-g001"><strong>Figure 1</strong></a> and data not shown). These results suggested that the inducible Cre activity of <em>R26-CreER<sup>T</sup></em> transgenic mice had been successfully controlled by 4OHT in a variety of organs, although the level of inducible Cre activity may have differed as indicated by the variable X-gal stained intensity among these systemic organs.</p>
<div class="figure" id="pone-0001237-g001"><div class="img"><a name="pone-0001237-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Evaluation of 4OHT-induced Cre recombination in <em>R26CreER<sup>T</sup>; R26R</em> mice.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>After 10 days of 4OHT or vehicle control (DMSO) injection, <em>LacZ</em> reporter activity in the systemic organs including brain, liver, spleen, pancreas, kidney, intestine and reproductive tracts of <em>R26CreER<sup>T</sup>;R26R</em> mice (2 males and 2 females) were examined by X-gal staining and compared with those of the control mice. The representative X-gal staining patterns in the systemic organs of a DMSO-treated control male mouse and the reproductive organs of a control female mouse are shown in the left panels. Representative X-gal positive (blue) patterns reflecting inducible Cre activity are shown in the other panels (middle, 4OHT-treated <em>R26CreER<sup>T</sup>;R26R</em> female; right, 4OHT-treated <em>R26CreER<sup>T</sup>;R26R</em> male). A, adrenal gland; AP, anterior prostate; B, bladder; O, ovary; Ov, oviduct; SV, seminal vesicle; U, uterus; VD, vas deferens</p>
<span>doi:10.1371/journal.pone.0001237.g001</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>To investigate tumor susceptibility in the <em>Pten</em>-deficient mice at an adult stage, we generated <em>R26-CreER/+;Pten<sup>fx/fx</sup></em> (referred to as <em>R26-Pten<sup>fx/fx</sup></em> hereafter) and control (<em>R26-Pten<sup>fx/+</sup></em>, <em>Pten<sup>fx/+</sup></em> or <em>Pten<sup>fx/fx</sup></em>) mice and followed this with 4OHT induced Cre/loxP recombination to excise exon 5 of <em>Pten</em> gene (<a href="#pone-0001237-g002"><strong>Figure 2A</strong></a>). After 4OHT treatment for one week, we examined the efficiency of exon 5 of <em>Pten</em> gene excision using the genomic PCR method in a variety of organs dissected from males and females carrying the <em>Pten<sup>fx/+</sup></em>, <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> genotypes (<a href="#pone-0001237-g002"><strong>Figure 2B</strong></a>). Our result showed that exon 5 of the <em>Pten</em> gene excision was detected in <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> tissues, indicating that 4OHT was able to induce Cre-mediated excision of <em>lox</em>P-flanked region in the tissues examined (<a href="#pone-0001237-g002"><strong>Figure 2B</strong></a>). Notably, the excision efficiency of <em>Pten</em> showed no overt differences between males and females carrying the <em>R26-Pten<sup>fx/+</sup></em> or <em>R26-Pten<sup>fx/fx</sup></em> genotypes. However, inducible Cre activity may vary slightly across the organs of the <em>R26-Pten<sup>fx/+</sup></em> or <em>R26-Pten<sup>fx/fx</sup></em> mice (<a href="#pone-0001237-g002"><strong>Figure 2B</strong></a>). We next examined the expression of PTEN protein in selected organs, specifically the anterior prostate and the intestinal tract, of 4OHT-injected <em>R26-Pten<sup>fx/fx</sup></em> and control (<em>R26-Pten<sup>fx/+</sup></em>) mice using immunofluorescence microscopy. Our results showed that PTEN could be detected in the prostate and colon epithelium, which was indicated by cytokeratin 8 (CK8) staining of the controls (yellow; CK8-positive, PTEN-positive). In contrast, PTEN expression was lost in most of the hyperplastic epithelial lesions and tumor lesions (red; CK8-positive, PTEN-negative) found in the corresponding organs of the <em>R26-Pten<sup>fx/fx</sup></em> mice (<a href="#pone-0001237-g002"><strong>Figure 2C</strong></a>). We also examined the expression of PTEN in various other systemic organs, namely the lung and the kidney, of <em>R26-Pten<sup>fx/fx</sup></em> and the control mice to demonstrate PTEN loss (<a href="#pone.0001237.s001"><strong>Figure S1</strong></a>). Our results suggested that the majority of PTEN was lost from the systemic organs of the <em>R26-Pten<sup>fx/fx</sup></em> mice (<a href="#pone-0001237-g002"><strong>Figure 2B &amp; C</strong></a>; <a href="#pone.0001237.s001"><strong>Figure S1</strong></a>).</p>
<div class="figure" id="pone-0001237-g002"><div class="img"><a name="pone-0001237-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Temporally controlled <em>Pten</em> loss in <em>R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></em> mice.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>(A) Illustration of <em>Pten</em> conditional (floxed; fx) allele, <em>ROSA26-CreER<sup>T</sup></em> transgene and 4OHT-induced <em>Pten exon 5</em> excision. The <em>CreER<sup>T</sup></em> fusion protein (inactive) was initially expressed under a ubiquitous promoter ROSA26. The 4OHT inducer was used to temporally active the CreER<sup>T</sup> recombinase activity, which resulted in the excision of the DNA fragment containing the <em>Pten exon 5.</em> (B). PCR genotyping of the Pten floxed allele and Cre-mediated exon 5 excision; After one week of 4OHT injection, genomic DNA was isolated individually from multiple organs including the lung, the liver, the intestine, the kidney, the spleen, the thymus, the tail, the anterior prostate and the uterus of mice carrying different genotypes (C, <em>Pten<sup>fx/+</sup></em>; 1, <em>R26-Pten<sup>fx/+</sup></em> male; 2, <em>R26-Pten<sup>fx/+</sup></em> female; 3, <em>R26-Pten<sup>fx/fx</sup></em> male; 4, <em>R26-Pten<sup>fx/fx</sup></em> female). PCR genotyping is shown that allows the identification of the Pten floxed allele (~1100-bp), the wild-type (~1000-bp) and the exon 5 excised alleles (Δ5; ~400-bp) from the 4OHT-treated mice. (C). Immunostaining of PTEN in the prostate and the colon. Representative merged images of the immunofluorescence analysis reveal the expression level of PTEN in the anterior prostate lobe (at 7 weeks post-4OHT treatment) and the colon (at 37 weeks post-4OHT treatment) of the <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> mice. Antibody against PTEN (green) and TROMA-I antibody against cytokeratin 8 (CK8; red) were used to study the expression of PTEN in the simple epithelial subsets. Arrows indicated the coexpression of PTEN and CK8 (yellow) in anterior prostate gland and colon epithelium of <em>R26-Pten<sup>fx/+</sup></em> mice (left panels), whereas the hyperplastic epithelial subsets (middle panels; red) of the <em>R26-Pten<sup>fx/fx</sup></em> mice showing PTEN loss (arrowheads). In addition, the immunofluorescence images in the right panels reveal PTEN loss in the tumor lesions of prostate and colon of <em>R26-Pten<sup>fx/fx</sup></em> males (at 13 and 39 weeks, respectively). Scale Bar, 200 µm.</p>
<span>doi:10.1371/journal.pone.0001237.g002</span></div>

<h4>Analysis of <em>R26-Pten<sup>fx/fx</sup></em> and <em>R26-Pten<sup>fx/+</sup></em> malignancies</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Furthermore, <em>R26-Pten<sup>fx/fx</sup></em> (n = 33; 20 males and 13 females) and control (<em>Pten<sup>fx/fx</sup></em>, n = 24; <em>R26-Pten<sup>fx/+</sup></em>, n = 21) mice were given 4-OHT injection (i.p.) at age of 6 weeks and then monitored for tumor development over about 60 weeks. The mice were sacrificed for pathological analysis (H&amp;E and IHC) when they manifested sign of distress or on tumor detection. The cumulated tumor-free survival curves of the <em>R26-Pten<sup>fx/fx</sup></em> and control mice are shown in <a href="#pone-0001237-g003"><strong>Figure 3A</strong></a>. Our results showed that all the <em>R26-Pten<sup>fx/fx</sup></em> mice died from their tumor burden by 45 weeks post 4OHT injection (<a href="#pone-0001237-t001"><strong>Table 1</strong></a>). The overall mean latency of <em>Pten</em>-deficient tumor formation was 17 weeks. In addition, we found 4 <em>R26-Pten<sup>fx/+</sup></em> mice (19.0%) developed various different types of tumors by 60 weeks post 4OHT treatment (<a href="#pone-0001237-t001"><strong>Table 1</strong></a>). We found that one <em>R26-Pten<sup>fx/+</sup></em> mouse suffered from metastatic lung cancer at 42 weeks, two <em>R26-Pten<sup>fx/+</sup></em> females developed mammary tumors at 52 and 55 weeks and another <em>R26-Pten<sup>fx/+</sup></em> male mouse developed hepatocellular carcinoma at 58 weeks (<a href="#pone-0001237-t001"><strong>Table 1</strong></a>; <a href="#pone.0001237.s002"><strong>Figure S2</strong></a>). No tumors were found in the control group <em>Pten<sup>fx/fx</sup></em> mice at 60 weeks.</p>
<div class="figure" id="pone-0001237-g003"><div class="img"><a name="pone-0001237-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Tumor-free survival, tumor spectrum and tumor incidence of <em>R26-Pten<sup>fx/fx</sup></em> mice.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>(A) Tumor-free survival of <em>Pten<sup>fx/fx</sup></em>, <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> mice; (B) Tumor-free survival of male and female <em>R26-Pten<sup>fx/fx</sup></em> mice; (C) Tumor spectrum and incidence of male and female <em>R26-Pten<sup>fx/fx</sup></em> mice; Lym, lymphomas; PC, prostate cancer; EC, endometrial cancer; IC, intestinal cancer; SCC, squamous cell carcinoma; The percentage of each tumor type is shown on the right of bar graph. (D) Tumor latency of the <em>R26-Pten<sup>fx/fx</sup></em> mice; each dot represents an individual malignant tumor in the <em>R26-Pten<sup>fx/fx</sup></em> mice. ⧫, Lymphoma (Lym); ▪, Squamous cell carcinoma (SCC); ▴, Intestinal cancer (IC); •, prostate cancer (PC); Bars represent the mean tumor latency.</p>
<span>doi:10.1371/journal.pone.0001237.g003</span></div><div class="figure" id="pone-0001237-t001"><div class="img"><a name="pone-0001237-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Malignancies of <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> mice</span></strong></p><span>doi:10.1371/journal.pone.0001237.t001</span></div><a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>Interestingly, we found that the tumor latency and spectrum of the <em>Pten</em>-deficient mice exhibited gender differences. Approximately, 50% <em>R26-Pten<sup>fx/fx</sup></em> males and females had malignant tumors at 21 weeks and between 10 and 11 weeks, respectively (<a href="#pone-0001237-g003"><strong>Figure 3B</strong></a>). Most <em>R26-Pten<sup>fx/fx</sup></em> females quickly developed lymphomas (10 of 13; 76.9%) and died at about 9 weeks post-4OHT injection compared to a much lower incidence of lymphoma formation (8 of 20; 40%) by 13 weeks in the males (<a href="#pone-0001237-g003"><strong>Figure 3C</strong></a>). The <em>Pten</em>-deficient male mice developed intestinal cancers (7 of 20, 35%) arising from the colorectum (n = 6) and small intestine (n = 1), whereas no female mice developed this type of cancer. This might be partly due to the quick development of the lymphomas, which caused early lethality before the intestinal cancer could develop in the <em>R26-Pten<sup>fx/fx</sup></em> females. In addition, the <em>R26-Pten<sup>fx/fx</sup></em> mice developed squamous cell carcinoma of the epidermis (4 of 33 mice, 12.1%; 2 males, 10% and 2 females, 15.4%), endometrial cancer (6 of 13 females, 46.1%) and prostate cancer (4 of 20 males, 20%) (<a href="#pone-0001237-g003"><strong>Figure 3C</strong></a>). The mean latency of these malignancies is showed in <a href="#pone-0001237-g003"><strong>Figure 3D</strong></a>. The sequential occurrence of the <em>Pten</em>-deficient malignancies was about 11 weeks for the lymphomas and the endometrial cancer, about 19 weeks for the prostate cancer and squamous cell carcinoma and about 30 weeks for the intestinal cancer (<a href="#pone-0001237-g003"><strong>Figure 3D</strong></a>).</p>
<a id="article1.body1.sec2.sec2.p3" name="article1.body1.sec2.sec2.p3"></a><p>The lymphomas mainly arose from the thymus and mesenteric lymph nodes. A representative thymic lymphoma is shown grossly in <a href="#pone-0001237-g004"><strong>Figure 4A</strong></a>. H&amp;E staining revealed a mature appearance for the small lymphocytic cells and a loss of cortical-medullary architecture in this thymic tumor (<a href="#pone-0001237-g004"><strong>Figure 4A</strong></a>). To verify the potential origins of this lymphoma, T-cell and B-cell origins were respectively determined by antibodies against CD3 and B220 in the liver with the infiltrated lymphoid tumor cells in the portal area identified using IHC, which showed that this tumor was a CD3-positive T-cell lymphoma (<a href="#pone-0001237-g004"><strong>Figure 4B</strong></a>). Through evaluation of CD3 and B220 expression in the lymphomas formed in the mutant mice, we found that all lymphomas were derived from CD3-positive T-cells with either a mature appearance of small lymphocytes or large lymphoblasts (data not shown). Occasionally, the more detail surface markers that were expressed on these lymphomas were analyzed by flow cytometry in order to assist our verification of these lymphomas. As an example, a CD4-rich T-cell lymphomas was found to have developed in a <em>R26-Pten<sup>fx/fx</sup></em> mouse at six weeks post-treatment (<a href="#pone-0001237-g004"><strong>Figure 4C</strong></a>). We also found that one mouse developed both CD4- and CD8-rich lymphomas arising from the thymus and mesenteric lymph node, respectively, suggesting that 4OHT-induced <em>Pten</em> loss in different lymphoid origins may develop simultaneously (data not shown).</p>
<div class="figure" id="pone-0001237-g004"><div class="img"><a name="pone-0001237-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Characterization of <em>R26-Pten<sup>fx/fx</sup></em> lymphomas.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>(A) Gross morphology of a <em>R26-Pten<sup>fx/fx</sup></em> thymic tumor enlarged compared to the control (ctrl) thymus. H&amp;E stained section of a <em>R26-Pten<sup> fx/fx</sup></em> thymic tumor reveals the morphology of the small lymphocytic cells in comparison to the control (ctrl). C, cortex; M, medulla; Scale Bar, 200 µm (B) Infiltrated lymphocytic tumor cells (arrows) in the liver of a <em>R26-Pten<sup>fx/fx</sup></em> mouse characterized by H&amp;E (left) and IHC antibodies against CD3 (middle; positive stained brown cells) and B220 (right; negative stained blue cells), which allow the assessment of the origin of the tumor. Scale bar, 200m; High-power views of CD3 or B220 IHC are inserted (scale bar, 100 µm). (C) Flow cytometry analysis of thymocyte suspensions from a control and a <em>R26-Pten<sup>fx/fx</sup></em> mouse stained with antibodies against CD4 and CD8. Percentage of cells is indicated in each quadrant.</p>
<span>doi:10.1371/journal.pone.0001237.g004</span></div><a id="article1.body1.sec2.sec2.p4" name="article1.body1.sec2.sec2.p4"></a><p>In addition to lymphomas, prostate cancer, endometrial cancer, intestinal cancer and squamous cell carcinoma of the epidermis were found in <em>R26-Pten<sup>fx/fx</sup></em> mice using H&amp;E and IHC analyses (<a href="#pone-0001237-g003"><strong>Figures 3</strong></a><strong> &amp; </strong><a href="#pone-0001237-g005"><strong>5</strong></a>). The focal invasions of the prostate, endometrial and colorectal carcinomas were observed and characterized by H&amp;E or IHC using antibodies against E-cadherin (<a href="#pone-0001237-g005"><strong>Figure 5</strong></a>). Pre-cancer lesions (hyperplasia/dysplasia and adenoma) of corresponding malignancies were also observed in the <em>R26-Pten<sup>fx/fx</sup></em> mice (<a href="#pone-0001237-g006"><strong>Figure 6</strong></a>). We found that <em>R26-Pten<sup>fx/fx</sup></em> males had developed small or large intestinal polyps at late onset (&gt;35 weeks; <a href="#pone-0001237-g006"><strong>Figure 6A &amp; B</strong></a>). In addition, most mutant females developed endometrial hyperplasia (7 of 13) at between 7 and 9 weeks post-4-OHT injection (<a href="#pone-0001237-g006"><strong>Figure 6C</strong></a>). The early alternations associated with prostate hyperplasia (BPH) or prostate intraepithelial neoplasm (PIN) were observed at 4~6 weeks post 4-OHT injection (<a href="#pone-0001237-g006"><strong>Figure 6D</strong></a>).</p>
<div class="figure" id="pone-0001237-g005"><div class="img"><a name="pone-0001237-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span><em> R26-Pten<sup>fx/fx</sup></em> epithelial malignancies.</span></strong></p><a id="article1.body1.sec2.sec2.fig3.caption1.p1" name="article1.body1.sec2.sec2.fig3.caption1.p1"></a><p>Representative histology (middle panels; H&amp;E) and E-cadherin IHC (right panels; E-cad; NovaRed) of malignant tumors of <em>R26-Pten<sup>fx/fx</sup></em> prostate, uterus, colorectum and skin tissue are showed to compare with the normal corresponding organs (left panels; H&amp;E) from control mice. Red arrowheads indicated the invasive border of the prostatic, endometrial and colorectal cancers. High-magnification views of E-cadherin IHC revealing intense membranous staining are shown in the inserted photos (Bars, 100 µm). Bidirectional arrows indicated the endometrial portions. M, myometrium; E, endometrium; Scale bars, 200 µm.</p>
<span>doi:10.1371/journal.pone.0001237.g005</span></div><div class="figure" id="pone-0001237-g006"><div class="img"><a name="pone-0001237-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>Pre-cancer lesions of <em>R26-Pten<sup>fx/fx</sup></em> mice.</span></strong></p><a id="article1.body1.sec2.sec2.fig4.caption1.p1" name="article1.body1.sec2.sec2.fig4.caption1.p1"></a><p>(A &amp; B) Representative H&amp;E stained sections revealed the polyps of the small intestine (A) and the colon (B) of <em>R26-Pten<sup>fx/fx</sup></em> males at 31 and 39 weeks 4OHT post-treatment, respectively. (C) Representative H&amp;E stain revealing complex atypical hyperplasia of the endometrim was found in a <em>R26-Pten<sup>fx/fx</sup></em> female, which also suffered from lymphoma, at 11 weeks 4OHT post-treatment. M, myometrium; (D) Representative histology of high grade PIN was found in a <em>R26-Pten<sup>fx/fx</sup></em> male at 7 weeks post 4OHT injection. Arrowheads indicated the dysplastic epithelial lesions of the intestine (A &amp; B), the uterus (C) and the anterior prostate gland (D) of <em>R26-Pten<sup>fx/fx</sup></em> mice. Scale bars, 200 µm.</p>
<span>doi:10.1371/journal.pone.0001237.g006</span></div><a id="article1.body1.sec2.sec2.p5" name="article1.body1.sec2.sec2.p5"></a><p>Moreover, multiple tumors were also observed in <em>R26-Pten<sup>fx/fx</sup></em> mice (9 of 33, 27.3%; 5 females and 4 males). Among these animals, all females developed T-cell lymphoma and endometrial cancer at 7~23 weeks post-4OHT injection. One of these females also developed squamous cell carcinoma additionally. Furthermore, two males developed prostate cancer together with lymphoma (at 13 weeks) and colorectal cancer (at 27 weeks), respectively. Finally, two males developed squamous cell carcinomas and colorectal cancer at 28 and 31 weeks post-4OHT injection.</p>


<h4>Temporally controlled prostate tumorigenesis</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>The advantage of the use of inducible CreER<sup>T</sup>/<em>lox</em>P technology in this report is that it allowed the monitoring of tumor development at specific time points after 4-OHT injection. To investigate the progression of <em>Pten</em>-deficient malignancies, prostate cancer progression was chosen as the initial model because a good understanding of the role of <em>Pten</em> in this disease has been gained from other prostate-specific <em>Pten</em> knockout mouse model studies <a href="#pone.0001237-Wang1">[20]</a>, <a href="#pone.0001237-Ma1">[21]</a>, <a href="#pone.0001237-Trotman1">[23]</a>, <a href="#pone.0001237-Wang2">[25]</a>. At 4 weeks, 6 weeks and 30 weeks after 4-OHT injection, we found gradually enlargement of the anterior prostate in <em>R26-Pten<sup>fx/fx</sup></em> mice compared to the controls (<a href="#pone-0001237-g007"><strong>Figure 7A</strong></a>). Histologically, these prostate lesions were studied at the above time points (4, 6 and 30 weeks) and this revealed the prostate cancer progression through BPH/PIN to invasive cancer (<a href="#pone-0001237-g007"><strong>Figure 7A</strong></a>). We then determined activation of AKT using antibody against phosphorylated AKT (p-AKT-Ser473) specifically. We found that AKT phosphorylation appeared in all prostate lesions along with hyperplasia and neoplasia in the <em>R26-Pten<sup>fx/fx</sup></em> mice, unlike the controls (<a href="#pone-0001237-g007"><strong>Figure 7B</strong></a>). To identify the potential cell type of the <em>Pten</em>-deficient prostate cancer, we performed double immunofluorescent staining to verify the presence of cytokeratin 5 (CK5<sup>+</sup>)-expressing basal cells and cytokeratin 8 (CK8<sup>+</sup>)-expressing lumen epithelial cells from the normal, BPH, PIN and prostate cancer samples in the <em>R26-Pten<sup>fx/fx</sup></em> mice compared with the controls. Flattened and discontinuous CK5<sup>+</sup>-expressing cells were observed underneath the CK8<sup>+</sup>-expressing lumen epithelium in the control prostate, whereas stratification of the CK8<sup>+</sup> lumen epithelium together with flatten CK5<sup>+</sup> basal cells were noticed in the BPH/PIN lesions (<a href="#pone-0001237-g007"><strong>Figure 7C</strong></a>). As the disease progressed to invasive prostate cancer in the <em>R26-Pten<sup>fx/fx</sup></em> males, focal expansion of the CK5<sup>+</sup> cells and coexpression of the CK5<sup>+</sup>/CK8<sup>+</sup> cells were significantly increased (<a href="#pone-0001237-g007"><strong>Figure 7C</strong></a>). However, the significance of the increased CK5/CK8 double positive cells in the <em>Pten</em>-deficient prostate cancer remains unclear.</p>
<div class="figure" id="pone-0001237-g007"><div class="img"><a name="pone-0001237-g007" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g007&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g007"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g007&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g007.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g007/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g007.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 7.  <span>Prostate tumor progression of the <em>R26-Pten<sup>fx/fx</sup></em> prostate.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>(A) Gross view (upper panels) and H&amp;E staining (lower panels) of the anterior prostate of control (at 27 weeks 4OHT post-treatment) and of <em>R26-Pten<sup>fx/fx</sup></em> mice (at 4 weeks, 6 weeks and 30 weeks after 4OHT post-treatment); B, bladder; SV, seminal vesicle; AP (encircled in upper panels), anterior prostate; Arrows indicate the invasive border of the prostate epithelium and stroma. (B) IHC of p-AKT (Ser473) reveal the strong membranous localization of p-AKT in the BPH, PIN and prostate cancer samples of the <em>R26-Pten<sup>fx/fx</sup></em> mice compared to the normal epithelium of the control mice. (C) IF with antibodies against CK5 (green) and CK8 (red) reveal stratification and expansion of the basal and lumen epithelium in the BPH, PIN and prostate cancer samples of the <em>R26-Pten<sup>fx/fx</sup></em> mice compared to the normal epithelium of the control mice. Arrows indicate the focal CK5/CK8 (K5/K8) double-positive cells.</p>
<span>doi:10.1371/journal.pone.0001237.g007</span></div>

<h4>The PI3K inhibitor, LY294002, suppresses prostate hyperplasia</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>We next evaluated the effect of the potential cancer targeting agent LY294002, which is a potent inhibitor of PI3K-AKT signaling pathway in <em>Pten</em>-deficient prostate tumor progression. After LY294002 treatment for 4 weeks, we found that the apparent increased anterior prostate weight in <em>R26-Pten<sup>fx/fx</sup></em> mice (n = 4) was significantly suppressed (<em>p</em> = 0.007) in comparison to the controls (LY294002-treated <em>Pten<sup>fx/fx</sup></em> mice, n = 3; vehicle-treated <em>R26-Pten<sup>fx/fx</sup></em> mice, n = 3; <a href="#pone-0001237-g008"><strong>Figure 8A</strong></a>). Histological H&amp;E staining revealed that the increased cellularity and nuclear atypia of the anterior prostate were diminished in LY294002 treated <em>R26-Pten<sup>fx/fx</sup></em> mice compared with the untreated mice (<a href="#pone-0001237-g008"><strong>Figure 8B</strong></a>). We next examined whether LY294002 treatment blocked the PI3K-AKT signaling pathway. Using IHC, we found that only focal epithelial lesions showed pAKT(Ser473)-positive staining in LY294002 treated <em>R26-Pten<sup>fx/fx</sup></em> prostates, suggesting that LY294002 treatment strongly suppresses AKT phosphorylation at Ser473 in <em>R26-Pten<sup>fx/fx</sup></em> mice compared to the untreated animals (<a href="#pone-0001237-g008"><strong>Figure 8B</strong></a>). Therefore, our results demonstrated that inhibition of the PI3K-AKT pathway was sufficient to suppress <em>Pten</em>-deficient prostate hyperplasia.</p>
<div class="figure" id="pone-0001237-g008"><div class="img"><a name="pone-0001237-g008" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g008&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001237" data-uri="info:doi/10.1371/journal.pone.0001237.g008"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001237.g008&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g008.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001237.g008/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001237.g008.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 8.  <span>Suppressive effect of LY294002 on the <em>Pten</em>-deficient prostate enlargement.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>(A) The bar graph represented the relative weight (mean) of the anterior prostate lobe (AP weight in mg/body weight in g) of each group (n&gt; = 3). The <em>p</em> value was calculated by Student's <em>t</em>-test. Error bars represent the standard derivation. (B) Dissected anterior prostates of control (<em>Pten<sup>fx/fx</sup></em>) and of <em>R26-Pten<sup>fx/fx</sup></em> mice in the absence or presence of LY294002 for 4 weeks; these are shown as a gross view (upper panels) and with H&amp;E staining (middle panels). IHC of p-AKT(Ser473) is shown in the lower panels. Arrow indicates the focal positive for p-AKT in the LY294002-treated <em>R26-Pten<sup>fx/fx</sup></em> prostate.</p>
<span>doi:10.1371/journal.pone.0001237.g008</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>In this study, we demonstrated that the tumor spectrum, tumor incidence and tumor latency during temporally controlled <em>Pten</em> loss in the mouse. This is the first <em>in vivo</em> analysis of <em>Pten</em>-deficient tumorigenesis in the systemic organs of the adult mouse. It is likely that lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the <em>Pten</em> gene is excised by 4OHT-induced Cre/<em>lox</em>P recombination in the mouse's adult tissues. Although we have observed that Cre-mediated <em>Pten</em> excision did slightly vary among the systemic organs of <em>R26-Pten<sup>fx/+</sup></em> or <em>R26-Pten<sup>fx/fx</sup></em> mice, the variation seemed to show no correlation with the occurrence of <em>Pten</em>-deficient malignancies. Neoplastic cells may initiate from a single cell or a small number of cells because they are highly susceptible to tumorigenesis after PTEN loss and therefore slight variations in the Cre-mediated <em>Pten</em> excision will not affect the presence of such foci. Clinical studies have shown that somatic alterations of <em>PTEN</em> are found in proximately 5% of lymphomas<a href="#pone.0001237-Sakai1">[30]</a>, 29% of prostate cancer <a href="#pone.0001237-Cairns1">[31]</a> and 34% of endometrial cancer <a href="#pone.0001237-Risinger1">[32]</a>. Moreover, germline <em>PTEN</em> mutation shows strong linkage to Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS). These are inherited tumor predisposition syndromes in which hamartomas may develop in the central nervous system, gastrointestinal tract, skin, breast and thyroid <a href="#pone.0001237-Marsh1">[33]</a>. Affected individuals of CD families also have a higher risk of malignancy in corresponding tissues <a href="#pone.0001237-Marsh1">[33]</a>, <a href="#pone.0001237-Sansal1">[34]</a>, <a href="#pone.0001237-Eng1">[35]</a>. Thus, our findings for the <em>R26-Pten<sup>fx/fx</sup></em> tumor malignancies resemble to some degree of the tumor spectrum observed in human <em>PTEN</em> genetic studies.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>Interestingly, the tumor latency and tumor spectrum of <em>R26-Pten<sup>fx/fx</sup></em> mice exhibit gender-bias. <em>Pten</em>-deficient females are predisposed to lymphoma with an early onset of about 7 weeks, which may preclude the formation of other malignancies; the result of this may be the overall gender differences in the tumor spectrum. Particularly, intestinal cancer was not observed in <em>Pten</em>-deficient females, which may partly be due to the longer period time required to develop intestinal cancer, namely 25 weeks to 35 weeks post 4OHT treatment in mutant male mice.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>Furthermore, we observed that only four mice heterozygous for the <em>Pten</em> floxed allele, among 21 <em>R26-Pten<sup>fx/+</sup></em> mice analyzed, developed a variety of malignancies (up to 60 weeks).The incidence (19.0%, 4 of 21), latency (42 to 58 weeks) and spectrum (lung, breast and liver cancers) of the malignant tumors in our <em>R26-Pten<sup>fx/+</sup></em> mice is quite different from that of a previous reported <em>Pten<sup>+/−</sup></em> mouse model <a href="#pone.0001237-Stambolic2">[9]</a>. This report described approximately 18% lymphomas, 22% uterine cancer and 49% breast cancer occurring at ages ranging from 26 to 65 weeks. This discrepancy may be explained by the focal or mosaic excised activity of Cre/<em>lox</em>P-mediated recombination in the <em>R26-Pten<sup>fx/+</sup></em> mice. In addition, it is possible that the genetic background of the two mouse models or some other undefined mechanism may affect the tumor latency and spectrum between the different mouse models of <em>Pten</em> heterozygosity <a href="#pone.0001237-DiCristofano1">[8]</a>, <a href="#pone.0001237-Suzuki1">[11]</a>, <a href="#pone.0001237-Podsypanina1">[12]</a>, <a href="#pone.0001237-Freeman2">[36]</a>. In a previous study, Freeman et al. reported that tumorigenesis in <em>Pten</em> heterozygotes was strongly affected by the genetic background of the mouse <a href="#pone.0001237-Freeman2">[36]</a>. Mutant mice with a 129;C57BL6 background tend to have a higher incidence of lymphoid and endometrial malignancies. In contrast, <em>Pten</em> heterozygotes with a 129;BALB/c background develop prostate cancer more frequently. These findings are significant because they suggest that there are different modifier(s) present in different mouse strains that affect tumorigenesis in the mice after <em>Pten</em> loss. However, it remains unclear currently whether such background differences or putative modifier(s) are able to efficiently contribute to tumorigenesis in bi-allelic <em>Pten</em> loss. This might be further examined by generating <em>R26-Pten<sup>fx/fx</sup></em> mice with different genetic backgrounds or different mutant strains in the future.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>Although the multiple tumors that occurred simultaneously in the <em>Pten</em>-deficient mice may have complicated the monitoring of tumor formation compared to other mouse models that have used <em>Pten</em> ablation in a tissue-specific manner, our study is able to provide knowledge that will help an understanding of <em>Pten</em> tumor suppressor functional requirements in multiple tissue lineages and cells. In addition, the latency of the different <em>Pten</em>-deficient cancers provides a valuable time frame for a more detailed dissection in the future of the downstream effectors of <em>Pten</em> loss using pharmacological or genetic approaches. In this study, we tested the pharmacological inhibition of the <em>Pten</em> downstream signaling cascade using the PI3K inhibitor, LY294002, which has been demonstrated to suppress tumor outgrowth in xenografted ovarian tumors and pancreatic cancer cells in the nude mice <a href="#pone.0001237-Hu1">[37]</a>, <a href="#pone.0001237-Bondar1">[38]</a>. Recently, Shukla <em>et al</em> showed that LY294002 treatment suppresses the invasive properties of several human prostate cancer cell lines <a href="#pone.0001237-Shukla1">[39]</a>. In our study, we found that prostate hyperplasia after induced <em>Pten</em> loss at an adult stage is suppressed by LY294002. To our knowledge, this is the first evidence to show tumor inhibitory activity of LY294002 in spontaneous tumor formation using a genetically engineered mouse model. Moreover, recent reports have shown that mTOR inhibition effectively suppresses neuronal hypertrophy, endometrial hyperplasia and leukemia initiation after tissue-specific <em>Pten</em> loss or in the <em>Pten<sup>+/−</sup></em> mice <a href="#pone.0001237-Yilmaz1">[24]</a>, <a href="#pone.0001237-Kwon1">[40]</a>, <a href="#pone.0001237-Milam1">[41]</a>. Likewise, mTOR inhibition could also be tested in our temporal controlled <em>Pten</em>-deficient tumor model and this will allow the dissection of mTOR pathway requirements when <em>Pten</em> is lost in systemic organs.</p>
<a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>In summary, we utilized an inducible Cre/<em>lox</em>P system to ablate <em>Pten</em> in a temporal-specific manner in the adult mouse. Through the monitoring of tumor spectrum, tumor latency and tumor incidence in the <em>Pten</em>-deficient mice, our findings provide an entry point for an understanding the role of <em>Pten</em> in tumorigenesis across different tissues. Furthermore, these 4OHT-inducible <em>R26CreER<sup>T</sup>; Pten<sup>fx/fx</sup></em> mice will be a useful mouse model that can be used to identify and study potential therapeutic approaches that will prevent <em>Pten</em>-deficient malignancies.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Mice</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p><em>Pten<sup>fx/fx</sup></em> <a href="#pone.0001237-Lesche1">[28]</a>, <a href="#pone.0001237-Groszer1">[29]</a>, <em>ROSA26 Cre reporter (R26R)</em> <a href="#pone.0001237-Mao1">[42]</a> and <em>R26</em>-<em>CreER<sup>T</sup></em> <a href="#pone.0001237-Badea1">[27]</a> mice were obtained from the Jackson Laboratory (Jackson Laboratory, Bar Harbor, ME, USA). <em>R26-CreER/+;R26R/+</em> bigenic mice were generated in order to examine the effect of inducible Cre activity in the systemic organs. <em>R26-CreER<sup>T</sup>/+;Pten<sup>fx/fx</sup></em> and the control (<em>R26-CreER<sup>T</sup>/+;Pten<sup>fx/+</sup></em> or <em>Pten<sup>fx/fx</sup></em>) mice were generated in a mixed background (BALB/c;129;C57BL/6) by crossing <em>Pten<sup>fx/fx</sup></em> and <em>R26-CreER<sup>T</sup></em> mice; this was followed by crossing <em>R26-CreER<sup>T</sup>/+;Pten<sup>fx/+</sup></em> and <em>Pten<sup>fx/fx</sup></em> mice. Up to five mice were housed in microisolator cages and provided with autoclaved food and water in a specific pathogen free colony. The experimental procedures using animals were in accordance with the guidelines of Institutional Animal Care and Use Committee. PCR genotyping was performed according to the standard protocols.</p>


<h4>Pharmacologically administration</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>4-hydroxytamoxifen (4-OHT; Sigma-Aldrich, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) at a concentration of 10 mg/ml. 4-OHT solution was emulsified in sunflower seed oil (Sigma-Aldrich) by vortexing, which was followed by mixing on a rotator for 4~6 hours. The mice at the age of 6 weeks were injected intraperitoneally with a dose of 4-OHT (4~5g per gram body weight) every other day three times. Similarly, LY294002 (Calbiochem, La Jolla, CA, USA) was prepared using the same procedure as 4-OHT. For the LY294002 administration, mice were injected intraperitoneally with LY294002 (4~5g per gram body weight) one week after the 4OHT treatment.</p>


<h4>Whole mount X-gal staining</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>The systemic organs including brain, lung, liver, spleen, pancreas, lung, kidney, stomach, intestine and reproductive system were dissected. Organs were fixed transiently with 10% neutral-buffered formalin for 30 minutes and rinsed with rinse buffer (2 mM MgCl<sub>2</sub>, 0.1% sodium deoxycholate, 0.2% NP-40, 1× PBS, pH7.3) for 30 minutes. Organs were incubated with X-gal staining solution (5 mM potassium hexacyanoferrate, 5 mM potassium hexacynoferrate trihydrate, 1 mg/ml X-gal in rinse buffer) for 1 hour at 37°C or room temperature with gentle agitation until the appearance of blue coloration and then organs in X-gal staining solution were transferred to 4°C refrigerator overnight. Finally, stained organs were post-fixed with neutral-buffered formalin overnight and stored in 70% ethanol at 4°C or photography examined by stereomicroscopy (MZ6, Leica, Germany).</p>


<h4>Analyses of tumor-free survival and tumor malignancy</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>The tumor-free survival rate was analyzed using the Kalpan-Meier method by the SPSS program (SPSS, Inc., Chicago, IL, USA). Detail analysis of tumor formation has been described previously <a href="#pone.0001237-Chen2">[43]</a>, <a href="#pone.0001237-Chen3">[44]</a>. Briefly, mice were inspected for illness or tumor formation twice every week. Normal tissues or tumor samples were isolated and fixed in 10% neutral-buffered formalin at 4°C overnight. Subsequently, the samples were embedded in paraffin and further processed for histopathological studies as described below. Lung, kidney, liver and enlarged lymph nodes were also isolated to histologically to be examined for metastasis. If tumors were not identified by gross examination, then a necropsy was performed. Diagnosis of tumor malignancy was carried out in consultation with pathologists. In general, tissue sections stained by hematoxylin and eosin (H&amp;E; see below) were examined by light microscopy (BX51, Olympus, Japan). Tumor malignancy was characterized by invasive behavior or metastasis. Expansive tumor lesions, but with a relatively normal cytological appearance and not showing an invasive behavior, were considered as benign or pre-cancerous.</p>


<h4>Hematoxylin and eosin (H&amp;E) staining</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>Tissue sections on slides were deparaffinized and rehydrated and this was followed by staining with Harris Hematoxylin (DakoCytomation, Denmark) for 3~5 minutes. Sections were washed with ddH<sub>2</sub>O and then transferred to Tris-HCl (pH 8.0) for 5 minutes. Subsequently, the sections were stained with Eosin Y (Shandon, Tokyo, Japan) for 30 seconds, dehydrated and then mounted.</p>


<h4>Immunohistochemical (IHC) and immunofluorescence studies (IF)</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>Tissue sections were deparaffinized, rehydrated and placed in boiling antigen retrieval buffer (DakoCytomation). Endogenous peroxidase activity was quenched by 3% hydrogen peroxide for 5 minutes and this was followed by incubation with blocking reagent (1% Cold Water Fish Skin Gelatin, 5% Bovine Serum Albumin in 1× Phosphate Buffered Saline) for 1 hour at room temperature. For IHC, the tissues sections were subsequently incubated with primary antibodies against CD3 (ready to use; Abcam Ltd, Cambridge, UK), B220 (1:50 dilution; Southern Biotech, Birmingham, AL, USA;), E-cadherin (1:50 dilution; DakoCytomation) and p-AKT(Ser473) (1:100 dilution; Cell Signaling Technology, Beverly, MA, USA) for 1 hour at room temperature The tissue sections was then incubated with biotinylated-linked secondary antibody (anti-mouse/rabbit; DakoCytomation) for 30 minutes and Streptavidin-HRP (DakoCytomation) was added to amplify the signals. Staining was performed using a NovaRed substrate kit (Vector Laboratories, Burlingame, CA). The slides were counterstained for a short time with Hematoxylin, which was followed by dehydration and then mounting. For IF, tissues sections were incubated with primary antibodies against PTEN (1:12500 dilution; Cascade BioScience, Winchester, MA), cytokeratin 5 (CK5, 1:400 dilution; Abcam) and/or cytokeratin 8 (CK8 or TROMA-1, 1:400, Developmental Study Hybridoma Bank, University of Iowa, Iowa City, IA, USA). Secondary antibodies (AlexaFluor 568 conjugated anti-rat IgG against antibody to CK8 and AlexaFluor 488 conjugated anti-rabbit IgG against antibody to CK5; Molecular Probes, Invitrogen) were next incubated on the slides for 1 hour and this was followed by DAPI staining for 2 minutes. A tyramide signaling amplification (TSA) system (kit#22 with HRP-streptavidin and AlexaFluor 488, Invitrogen) was used to enhance the PTEN signal. Finally, the slides were further incubated with DAPI for 2 minutes and mounted in fluorescent mounting medium (DakoCytomation).</p>


<h4>Flow cytometry analysis</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>The control or enlarged lymphoid organs (thymus and lymph nodes) were dissected and collected in DMEM medium. These lymphoid tissues were grounded and filtrated through cell strainers. The cells present were counted and then centrifuged for 5 minutes at 4°C. Then, the cell suspensions were incubated with 2.4G2 monoclonal antibody (a gift from Dr Jeffery J.Y. Yen) for 30 minutes on ice followed by labeling with FITC-conjugated antibodies against CD4 (eBioscience, San Diego, CA, USA) and PE-conjugated antibody against CD8 (eBioscience) for 15 minutes. After washing the cell pellets twice with 1xPBS, the cells were resuspended in 1xPBS containing Propidium Iodine (1g/ml, eBioscience). The percentage of live cells (PI exclusive) expressing the CD4/CD8 surface markers were analyzed by flow cytometry (FACScalibur, Becton Dickinson, USA) using Cell Quest software.</p>

</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0001237"></div><a name="pone.0001237.s001" id="pone.0001237.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001237.s001">Figure S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="preSiDOI">Immunofluorescence analysis of PTEN expression. After one week of 4OHT injection, PTEN expression was determined using antibody against PTEN (green) and counterstained with DAPI (blue) in the lung and the kidney of the <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> mice.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001237.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(1.01 MB TIF)</p>
<a name="pone.0001237.s002" id="pone.0001237.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001237.s002">Figure S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1"></a><p class="preSiDOI"><em>R26-Pten<sup>fx/+</sup></em> malignancies. (A) H&amp;E-stained section of a lung cancer shows the bronchioloalveolar features found in a <em>R26-Pten<sup>fx/+</sup></em> male at 42 weeks post 4OHT treatment. (B) H&amp;E-stained section showing lung cancer metastasis in the liver of the same mouse described in A. (C) H&amp;E-stained section of a mammary gland tumor showing lobular intraductal proliferation and microinvasion patterns in a <em>R26-Pten<sup>fx/+</sup></em> female at 52 weeks. (D) H&amp;E-stained section of a liver cancer showing disarrangement of the sinusoids, trabecular or pseudoglandular features with scattered hyaline bodies in a <em>R26-Pten<sup>fx/+</sup></em> male at 58 weeks. High magnification views in <em>C</em> and <em>D</em> showing mitotic figures (arrowheads) have been inserted (Bar, 100m). Bars in <em>A~D</em>, 200m. T, tumor lesion.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001237.s002</p><a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(1.91 MB TIF)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>We thank Drs. Ming-Ji Fann and Yu-Ting Yan for helpful comments, Drs Ting-Fen Tsai and Ching-Wei Luo for sharing of reagents and equipments and Dr Ralph Kirby for proofreading of this manuscript.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: CC TL LY JC. Performed the experiments: CC TL CL JC. Analyzed the data: CC TL CL JC. Contributed reagents/materials/analysis tools: CC LY. Wrote the paper: CC.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001237-Stambolic1" id="pone.0001237-Stambolic1"></a>Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al.  (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell  95: 29–39.  <ul class="find" data-citedArticleID="1023398" data-doi="10.1016/s0092-8674(00)81780-8"><li><a href="http://dx.doi.org/10.1016/s0092-8674(00)81780-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Negative+regulation+of+PKB%2FAkt-dependent+cell+survival+by+the+tumor+suppressor+PTEN." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Negative+regulation+of+PKB%2FAkt-dependent+cell+survival+by+the+tumor+suppressor+PTEN.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001237-Wu1" id="pone.0001237-Wu1"></a>Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A  95: 15587–15591.  <ul class="find" data-citedArticleID="1023416" data-doi="10.1073/pnas.95.26.15587"><li><a href="http://dx.doi.org/10.1073/pnas.95.26.15587" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+PTEN%2FMMAC1+tumor+suppressor+phosphatase+functions+as+a+negative+regulator+of+the+phosphoinositide+3-kinase%2FAkt+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+PTEN%2FMMAC1+tumor+suppressor+phosphatase+functions+as+a+negative+regulator+of+the+phosphoinositide+3-kinase%2FAkt+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001237-Maehama1" id="pone.0001237-Maehama1"></a>Maehama T, Dixon JE (1999) PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol  9: 125–128.  <ul class="find" data-citedArticleID="1023378" data-doi="10.1016/s0962-8924(99)01519-6"><li><a href="http://dx.doi.org/10.1016/s0962-8924(99)01519-6" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN%3A+a+tumour+suppressor+that+functions+as+a+phospholipid+phosphatase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN%3A+a+tumour+suppressor+that+functions+as+a+phospholipid+phosphatase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001237-Cully1" id="pone.0001237-Cully1"></a>Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer  6: 184–192.  <ul class="find" data-citedArticleID="1023348" data-doi="10.1038/nrc1819"><li><a href="http://dx.doi.org/10.1038/nrc1819" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Beyond+PTEN+mutations%3A+the+PI3K+pathway+as+an+integrator+of+multiple+inputs+during+tumorigenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001237-Steck1" id="pone.0001237-Steck1"></a>Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, et al.  (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet  15: 356–362.  <ul class="find" data-citedArticleID="1023402" data-doi="10.1038/ng0497-356"><li><a href="http://dx.doi.org/10.1038/ng0497-356" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+a+candidate+tumour+suppressor+gene%2C+MMAC1%2C+at+chromosome+10q23.3+that+is+mutated+in+multiple+advanced+cancers." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+a+candidate+tumour+suppressor+gene%2C+MMAC1%2C+at+chromosome+10q23.3+that+is+mutated+in+multiple+advanced+cancers.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001237-Li1" id="pone.0001237-Li1"></a>Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al.  (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science  275: 1943–1947.  <ul class="find" data-citedArticleID="1023374" data-doi="10.1126/science.275.5308.1943"><li><a href="http://dx.doi.org/10.1126/science.275.5308.1943" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001237-Teng1" id="pone.0001237-Teng1"></a>Teng DH, Hu R, Lin H, Davis T, Iliev D, et al.  (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res  57: 5221–5225.  <ul class="find" data-citedArticleID="1023408"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=MMAC1%2FPTEN+mutations+in+primary+tumor+specimens+and+tumor+cell+lines.&amp;auth=&amp;atitle=MMAC1%2FPTEN+mutations+in+primary+tumor+specimens+and+tumor+cell+lines." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=MMAC1%2FPTEN+mutations+in+primary+tumor+specimens+and+tumor+cell+lines." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22MMAC1%2FPTEN+mutations+in+primary+tumor+specimens+and+tumor+cell+lines.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001237-DiCristofano1" id="pone.0001237-DiCristofano1"></a>Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet  19: 348–355.  <ul class="find" data-citedArticleID="1023350" data-doi="10.1038/1235"><li><a href="http://dx.doi.org/10.1038/1235" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pten+is+essential+for+embryonic+development+and+tumour+suppression." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pten+is+essential+for+embryonic+development+and+tumour+suppression.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001237-Stambolic2" id="pone.0001237-Stambolic2"></a>Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, et al.  (2000) High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res  60: 3605–3611.  <ul class="find" data-citedArticleID="1023400"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=High+incidence+of+breast+and+endometrial+neoplasia+resembling+human+Cowden+syndrome+in+pten%2B%2F%3F+mice.&amp;auth=&amp;atitle=High+incidence+of+breast+and+endometrial+neoplasia+resembling+human+Cowden+syndrome+in+pten%2B%2F%3F+mice." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=High+incidence+of+breast+and+endometrial+neoplasia+resembling+human+Cowden+syndrome+in+pten%2B%2F%E2%88%92+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22High+incidence+of+breast+and+endometrial+neoplasia+resembling+human+Cowden+syndrome+in+pten%2B%2F%E2%88%92+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001237-Sun1" id="pone.0001237-Sun1"></a>Sun H, Lesche R, Li DM, Liliental J, Zhang H, et al.  (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A  96: 6199–6204.  <ul class="find" data-citedArticleID="1023404" data-doi="10.1073/pnas.96.11.6199"><li><a href="http://dx.doi.org/10.1073/pnas.96.11.6199" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN+modulates+cell+cycle+progression+and+cell+survival+by+regulating+phosphatidylinositol+3%2C4%2C5%2C-trisphosphate+and+Akt%2Fprotein+kinase+B+signaling+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN+modulates+cell+cycle+progression+and+cell+survival+by+regulating+phosphatidylinositol+3%2C4%2C5%2C-trisphosphate+and+Akt%2Fprotein+kinase+B+signaling+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001237-Suzuki1" id="pone.0001237-Suzuki1"></a>Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, et al.  (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol  8: 1169–1178.  <ul class="find" data-citedArticleID="1023406" data-doi="10.1016/s0960-9822(07)00488-5"><li><a href="http://dx.doi.org/10.1016/s0960-9822(07)00488-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=High+cancer+susceptibility+and+embryonic+lethality+associated+with+mutation+of+the+PTEN+tumor+suppressor+gene+in+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22High+cancer+susceptibility+and+embryonic+lethality+associated+with+mutation+of+the+PTEN+tumor+suppressor+gene+in+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001237-Podsypanina1" id="pone.0001237-Podsypanina1"></a>Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, et al.  (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A  96: 1563–1568.  <ul class="find" data-citedArticleID="1023388" data-doi="10.1073/pnas.96.4.1563"><li><a href="http://dx.doi.org/10.1073/pnas.96.4.1563" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mutation+of+Pten%2FMmac1+in+mice+causes+neoplasia+in+multiple+organ+systems." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mutation+of+Pten%2FMmac1+in+mice+causes+neoplasia+in+multiple+organ+systems.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001237-Kim1" id="pone.0001237-Kim1"></a>Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, et al.  (2002) Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A  99: 2884–2889.  <ul class="find" data-citedArticleID="1023366" data-doi="10.1073/pnas.042688999"><li><a href="http://dx.doi.org/10.1073/pnas.042688999" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cooperativity+of+Nkx3.1+and+Pten+loss+of+function+in+a+mouse+model+of+prostate+carcinogenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cooperativity+of+Nkx3.1+and+Pten+loss+of+function+in+a+mouse+model+of+prostate+carcinogenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001237-Chen1" id="pone.0001237-Chen1"></a>Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al.  (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature  436: 725–730.  <ul class="find" data-citedArticleID="1023342" data-doi="10.1038/nature03918"><li><a href="http://dx.doi.org/10.1038/nature03918" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Crucial+role+of+p53-dependent+cellular+senescence+in+suppression+of+Pten-deficient+tumorigenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Crucial+role+of+p53-dependent+cellular+senescence+in+suppression+of+Pten-deficient+tumorigenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001237-Freeman1" id="pone.0001237-Freeman1"></a>Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, et al.  (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell  3: 117–130.  <ul class="find" data-citedArticleID="1023356" data-doi="10.1016/s1535-6108(03)00021-7"><li><a href="http://dx.doi.org/10.1016/s1535-6108(03)00021-7" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN+tumor+suppressor+regulates+p53+protein+levels+and+activity+through+phosphatase-dependent+and+-independent+mechanisms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN+tumor+suppressor+regulates+p53+protein+levels+and+activity+through+phosphatase-dependent+and+-independent+mechanisms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001237-AbateShen1" id="pone.0001237-AbateShen1"></a>Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, et al.  (2003) Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res  63: 3886–3890.  <ul class="find" data-citedArticleID="1023332"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Nkx3.1%3B+Pten+mutant+mice+develop+invasive+prostate+adenocarcinoma+and+lymph+node+metastases.&amp;auth=&amp;atitle=Nkx3.1%3B+Pten+mutant+mice+develop+invasive+prostate+adenocarcinoma+and+lymph+node+metastases." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Nkx3.1%3B+Pten+mutant+mice+develop+invasive+prostate+adenocarcinoma+and+lymph+node+metastases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Nkx3.1%3B+Pten+mutant+mice+develop+invasive+prostate+adenocarcinoma+and+lymph+node+metastases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001237-DiCristofano2" id="pone.0001237-DiCristofano2"></a>Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP (2001) Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet  27: 222–224.  <ul class="find" data-citedArticleID="1023352" data-doi="10.1038/84879"><li><a href="http://dx.doi.org/10.1038/84879" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pten+and+p27KIP1+cooperate+in+prostate+cancer+tumor+suppression+in+the+mouse." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pten+and+p27KIP1+cooperate+in+prostate+cancer+tumor+suppression+in+the+mouse.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001237-Kwan1" id="pone.0001237-Kwan1"></a>Kwan KM (2002) Conditional alleles in mice: practical considerations for tissue-specific knockouts. Genesis  32: 49–62.  <ul class="find" data-citedArticleID="1023368" data-doi="10.1002/gene.10068"><li><a href="http://dx.doi.org/10.1002/gene.10068" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Conditional+alleles+in+mice%3A+practical+considerations+for+tissue-specific+knockouts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Conditional+alleles+in+mice%3A+practical+considerations+for+tissue-specific+knockouts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001237-Metzger1" id="pone.0001237-Metzger1"></a>Metzger D, Chambon P (2001) Site- and time-specific gene targeting in the mouse. Methods  24: 71–80.  <ul class="find" data-citedArticleID="1023384" data-doi="10.1006/meth.2001.1159"><li><a href="http://dx.doi.org/10.1006/meth.2001.1159" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Site-+and+time-specific+gene+targeting+in+the+mouse." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Site-+and+time-specific+gene+targeting+in+the+mouse.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001237-Wang1" id="pone.0001237-Wang1"></a>Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, et al.  (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell  4: 209–221.  <ul class="find" data-citedArticleID="1023412" data-doi="10.1016/s1535-6108(03)00215-0"><li><a href="http://dx.doi.org/10.1016/s1535-6108(03)00215-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Prostate-specific+deletion+of+the+murine+Pten+tumor+suppressor+gene+leads+to+metastatic+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Prostate-specific+deletion+of+the+murine+Pten+tumor+suppressor+gene+leads+to+metastatic+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001237-Ma1" id="pone.0001237-Ma1"></a>Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, et al.  (2005) Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res  65: 5730–5739.  <ul class="find" data-citedArticleID="1023376" data-doi="10.1158/0008-5472.can-04-4519"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-04-4519" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeted+biallelic+inactivation+of+Pten+in+the+mouse+prostate+leads+to+prostate+cancer+accompanied+by+increased+epithelial+cell+proliferation+but+not+by+reduced+apoptosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeted+biallelic+inactivation+of+Pten+in+the+mouse+prostate+leads+to+prostate+cancer+accompanied+by+increased+epithelial+cell+proliferation+but+not+by+reduced+apoptosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001237-Backman1" id="pone.0001237-Backman1"></a>Backman SA, Ghazarian D, So K, Sanchez O, Wagner KU, et al.  (2004) Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci U S A  101: 1725–1730.  <ul class="find" data-citedArticleID="1023334" data-doi="10.1073/pnas.0308217100"><li><a href="http://dx.doi.org/10.1073/pnas.0308217100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Early+onset+of+neoplasia+in+the+prostate+and+skin+of+mice+with+tissue-specific+deletion+of+Pten." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Early+onset+of+neoplasia+in+the+prostate+and+skin+of+mice+with+tissue-specific+deletion+of+Pten.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001237-Trotman1" id="pone.0001237-Trotman1"></a>Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, et al.  (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol  1: E59.  <ul class="find" data-citedArticleID="1023410" data-doi="10.1371/journal.pbio.0000059"><li><a href="http://dx.doi.org/10.1371/journal.pbio.0000059" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pten+dose+dictates+cancer+progression+in+the+prostate." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pten+dose+dictates+cancer+progression+in+the+prostate.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001237-Yilmaz1" id="pone.0001237-Yilmaz1"></a>Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, et al.  (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature  441: 475–482.  <ul class="find" data-citedArticleID="1023418" data-doi="10.1038/nature04703"><li><a href="http://dx.doi.org/10.1038/nature04703" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pten+dependence+distinguishes+haematopoietic+stem+cells+from+leukaemia-initiating+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pten+dependence+distinguishes+haematopoietic+stem+cells+from+leukaemia-initiating+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001237-Wang2" id="pone.0001237-Wang2"></a>Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, et al.  (2006) Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci U S A  103: 1480–1485.  <ul class="find" data-citedArticleID="1023414" data-doi="10.1073/pnas.0510652103"><li><a href="http://dx.doi.org/10.1073/pnas.0510652103" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Pten+deletion+leads+to+the+expansion+of+a+prostatic+stem%2Fprogenitor+cell+subpopulation+and+tumor+initiation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Pten+deletion+leads+to+the+expansion+of+a+prostatic+stem%2Fprogenitor+cell+subpopulation+and+tumor+initiation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001237-He1" id="pone.0001237-He1"></a>He XC, Yin T, Grindley JC, Tian Q, Sato T, et al.  (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet  39: 189–198.  <ul class="find" data-citedArticleID="1023362" data-doi="10.1038/ng1928"><li><a href="http://dx.doi.org/10.1038/ng1928" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN-deficient+intestinal+stem+cells+initiate+intestinal+polyposis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN-deficient+intestinal+stem+cells+initiate+intestinal+polyposis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001237-Badea1" id="pone.0001237-Badea1"></a>Badea TC, Wang Y, Nathans J (2003) A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci  23: 2314–2322.  <ul class="find" data-citedArticleID="1023336"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=A+noninvasive+genetic%2Fpharmacologic+strategy+for+visualizing+cell+morphology+and+clonal+relationships+in+the+mouse.&amp;auth=&amp;atitle=A+noninvasive+genetic%2Fpharmacologic+strategy+for+visualizing+cell+morphology+and+clonal+relationships+in+the+mouse." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+noninvasive+genetic%2Fpharmacologic+strategy+for+visualizing+cell+morphology+and+clonal+relationships+in+the+mouse." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+noninvasive+genetic%2Fpharmacologic+strategy+for+visualizing+cell+morphology+and+clonal+relationships+in+the+mouse.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001237-Lesche1" id="pone.0001237-Lesche1"></a>Lesche R, Groszer M, Gao J, Wang Y, Messing A, et al.  (2002) Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis  32: 148–149.  <ul class="find" data-citedArticleID="1023372" data-doi="10.1002/gene.10036"><li><a href="http://dx.doi.org/10.1002/gene.10036" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cre%2FloxP-mediated+inactivation+of+the+murine+Pten+tumor+suppressor+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cre%2FloxP-mediated+inactivation+of+the+murine+Pten+tumor+suppressor+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001237-Groszer1" id="pone.0001237-Groszer1"></a>Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, et al.  (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science  294: 2186–2189.  <ul class="find" data-citedArticleID="1023360" data-doi="10.1126/science.1065518"><li><a href="http://dx.doi.org/10.1126/science.1065518" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Negative+regulation+of+neural+stem%2Fprogenitor+cell+proliferation+by+the+Pten+tumor+suppressor+gene+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Negative+regulation+of+neural+stem%2Fprogenitor+cell+proliferation+by+the+Pten+tumor+suppressor+gene+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001237-Sakai1" id="pone.0001237-Sakai1"></a>Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M (1998) PTEN gene alterations in lymphoid neoplasms. Blood  92: 3410–3415.  <ul class="find" data-citedArticleID="1023392"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=PTEN+gene+alterations+in+lymphoid+neoplasms.&amp;auth=&amp;atitle=PTEN+gene+alterations+in+lymphoid+neoplasms." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN+gene+alterations+in+lymphoid+neoplasms." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN+gene+alterations+in+lymphoid+neoplasms.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001237-Cairns1" id="pone.0001237-Cairns1"></a>Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, et al.  (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res  57: 4997–5000.  <ul class="find" data-citedArticleID="1023340"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Frequent+inactivation+of+PTEN%2FMMAC1+in+primary+prostate+cancer.&amp;auth=&amp;atitle=Frequent+inactivation+of+PTEN%2FMMAC1+in+primary+prostate+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Frequent+inactivation+of+PTEN%2FMMAC1+in+primary+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Frequent+inactivation+of+PTEN%2FMMAC1+in+primary+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001237-Risinger1" id="pone.0001237-Risinger1"></a>Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res  57: 4736–4738.  <ul class="find" data-citedArticleID="1023390"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=PTEN%2FMMAC1+mutations+in+endometrial+cancers.&amp;auth=&amp;atitle=PTEN%2FMMAC1+mutations+in+endometrial+cancers." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=PTEN%2FMMAC1+mutations+in+endometrial+cancers." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22PTEN%2FMMAC1+mutations+in+endometrial+cancers.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001237-Marsh1" id="pone.0001237-Marsh1"></a>Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, et al.  (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet  7: 507–515.  <ul class="find" data-citedArticleID="1023382" data-doi="10.1093/hmg/7.3.507"><li><a href="http://dx.doi.org/10.1093/hmg/7.3.507" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mutation+spectrum+and+genotype-phenotype+analyses+in+Cowden+disease+and+Bannayan-Zonana+syndrome%2C+two+hamartoma+syndromes+with+germline+PTEN+mutation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mutation+spectrum+and+genotype-phenotype+analyses+in+Cowden+disease+and+Bannayan-Zonana+syndrome%2C+two+hamartoma+syndromes+with+germline+PTEN+mutation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001237-Sansal1" id="pone.0001237-Sansal1"></a>Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol  22: 2954–2963.  <ul class="find" data-citedArticleID="1023394" data-doi="10.1200/jco.2004.02.141"><li><a href="http://dx.doi.org/10.1200/jco.2004.02.141" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+biology+and+clinical+relevance+of+the+PTEN+tumor+suppressor+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+biology+and+clinical+relevance+of+the+PTEN+tumor+suppressor+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001237-Eng1" id="pone.0001237-Eng1"></a>Eng C (2000) Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet  37: 828–830.  <ul class="find" data-citedArticleID="1023354" data-doi="10.1136/jmg.37.11.828"><li><a href="http://dx.doi.org/10.1136/jmg.37.11.828" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Will+the+real+Cowden+syndrome+please+stand+up%3A+revised+diagnostic+criteria." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Will+the+real+Cowden+syndrome+please+stand+up%3A+revised+diagnostic+criteria.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001237-Freeman2" id="pone.0001237-Freeman2"></a>Freeman D, Lesche R, Kertesz N, Wang S, Li G, et al.  (2006) Genetic background controls tumor development in PTEN-deficient mice. Cancer Res  66: 6492–6496.  <ul class="find" data-citedArticleID="1023358" data-doi="10.1158/0008-5472.can-05-4143"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-05-4143" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genetic+background+controls+tumor+development+in+PTEN-deficient+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genetic+background+controls+tumor+development+in+PTEN-deficient+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001237-Hu1" id="pone.0001237-Hu1"></a>Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB (2000) In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res  6: 880–886.  <ul class="find" data-citedArticleID="1023364"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29.&amp;auth=&amp;atitle=In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22In+vivo+and+in+vitro+ovarian+carcinoma+growth+inhibition+by+a+phosphatidylinositol+3-kinase+inhibitor+%28LY294002%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001237-Bondar1" id="pone.0001237-Bondar1"></a>Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB, McConkey DJ (2002) Inhibition of the phosphatidylinositol 3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther  1: 989–997.  <ul class="find" data-citedArticleID="1023338"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Inhibition+of+the+phosphatidylinositol+3%3F-kinase-AKT+pathway+induces+apoptosis+in+pancreatic+carcinoma+cells+in+vitro+and+in+vivo.&amp;auth=&amp;atitle=Inhibition+of+the+phosphatidylinositol+3%3F-kinase-AKT+pathway+induces+apoptosis+in+pancreatic+carcinoma+cells+in+vitro+and+in+vivo." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inhibition+of+the+phosphatidylinositol+3%E2%80%B2-kinase-AKT+pathway+induces+apoptosis+in+pancreatic+carcinoma+cells+in+vitro+and+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inhibition+of+the+phosphatidylinositol+3%E2%80%B2-kinase-AKT+pathway+induces+apoptosis+in+pancreatic+carcinoma+cells+in+vitro+and+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001237-Shukla1" id="pone.0001237-Shukla1"></a>Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, et al.  (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer  121: 1424–1432.  <ul class="find" data-citedArticleID="1023396" data-doi="10.1002/ijc.22862"><li><a href="http://dx.doi.org/10.1002/ijc.22862" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activation+of+PI3K-Akt+signaling+pathway+promotes+prostate+cancer+cell+invasion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activation+of+PI3K-Akt+signaling+pathway+promotes+prostate+cancer+cell+invasion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001237-Kwon1" id="pone.0001237-Kwon1"></a>Kwon CH, Zhu X, Zhang J, Baker SJ (2003) mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A  100: 12923–12928.  <ul class="find" data-citedArticleID="1023370" data-doi="10.1073/pnas.2132711100"><li><a href="http://dx.doi.org/10.1073/pnas.2132711100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=mTor+is+required+for+hypertrophy+of+Pten-deficient+neuronal+soma+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22mTor+is+required+for+hypertrophy+of+Pten-deficient+neuronal+soma+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">41.
              </span><a name="pone.0001237-Milam1" id="pone.0001237-Milam1"></a>Milam MR, Celestino J, Wu W, Broaddus RR, Schmeler KM, et al.  (2007) Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model. Am J Obstet Gynecol  196: 247 e241–245.  <ul class="find" data-citedArticleID="1023386" data-doi="10.1016/j.ajog.2006.10.872"><li><a href="http://dx.doi.org/10.1016/j.ajog.2006.10.872" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reduced+progression+of+endometrial+hyperplasia+with+oral+mTOR+inhibition+in+the+Pten+heterozygote+murine+model." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reduced+progression+of+endometrial+hyperplasia+with+oral+mTOR+inhibition+in+the+Pten+heterozygote+murine+model.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">42.
              </span><a name="pone.0001237-Mao1" id="pone.0001237-Mao1"></a>Mao X, Fujiwara Y, Orkin SH (1999) Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci U S A  96: 5037–5042.  <ul class="find" data-citedArticleID="1023380" data-doi="10.1073/pnas.96.9.5037"><li><a href="http://dx.doi.org/10.1073/pnas.96.9.5037" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Improved+reporter+strain+for+monitoring+Cre+recombinase-mediated+DNA+excisions+in+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Improved+reporter+strain+for+monitoring+Cre+recombinase-mediated+DNA+excisions+in+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">43.
              </span><a name="pone.0001237-Chen2" id="pone.0001237-Chen2"></a>Chen CM, Behringer RR (2004) Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev  18: 320–332.  <ul class="find" data-citedArticleID="1023344" data-doi="10.1101/gad.1162204"><li><a href="http://dx.doi.org/10.1101/gad.1162204" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ovca1+regulates+cell+proliferation%2C+embryonic+development%2C+and+tumorigenesis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ovca1+regulates+cell+proliferation%2C+embryonic+development%2C+and+tumorigenesis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">44.
              </span><a name="pone.0001237-Chen3" id="pone.0001237-Chen3"></a>Chen CM, Chang JL, Behringer RR (2004) Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts. Oncogene  23: 7722–7725.  <ul class="find" data-citedArticleID="1023346" data-doi="10.1038/sj.onc.1208037"><li><a href="http://dx.doi.org/10.1038/sj.onc.1208037" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tumor+formation+in+p53+mutant+ovaries+transplanted+into+wild-type+female+hosts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tumor+formation+in+p53+mutant+ovaries+transplanted+into+wild-type+female+hosts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.XML" value="105805"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.PDF" value="7864653"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g001.PNG_L" value="797356"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g001.PNG_M" value="217826"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g001.PNG_S" value="22791"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g001.TIF" value="1006046"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g001.PNG_I" value="166084"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g002.PNG_L" value="670223"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g002.PNG_M" value="246146"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g002.PNG_S" value="20352"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g002.TIF" value="887302"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g002.PNG_I" value="129211"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g003.PNG_L" value="100674"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g003.PNG_M" value="44819"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g003.PNG_S" value="8406"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g003.TIF" value="141696"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g003.PNG_I" value="21150"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.t001.PNG_L" value="87323"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.t001.PNG_M" value="112488"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.t001.PNG_S" value="16391"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.t001.TIF" value="434318"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.t001.PNG_I" value="37247"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g004.PNG_L" value="995732"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g004.PNG_M" value="386161"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g004.PNG_S" value="16214"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g004.TIF" value="1359166"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g004.PNG_I" value="119641"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g005.PNG_L" value="1806684"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g005.PNG_M" value="672634"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g005.PNG_S" value="20969"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g005.TIF" value="2423254"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g005.PNG_I" value="202962"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g006.PNG_L" value="1494882"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g006.PNG_M" value="604108"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g006.PNG_S" value="18520"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g006.TIF" value="1985934"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g006.PNG_I" value="180850"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g007.PNG_L" value="1281756"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g007.PNG_M" value="491925"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g007.PNG_S" value="18730"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g007.TIF" value="1674106"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g007.PNG_I" value="154115"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g008.PNG_L" value="1045145"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g008.PNG_M" value="259135"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g008.PNG_S" value="18703"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g008.TIF" value="1424072"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.g008.PNG_I" value="142555"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.s001.TIF" value="1008794"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001237.s002.TIF" value="1907404"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001237&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001237" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001237&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001237&volume=&issue=&title=Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice&author_name=Tsai-Ling%20Lu%2C%20Junn-Liang%20Chang%2C%20Chih-Chia%20Liang%2C%20Li-Ru%20You%2C%20Chun-Ming%20Chen&start_page=1&end_page=13" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001237" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237&amp;t=Tumor%20Spectrum%2C%20Tumor%20Latency%20and%20Tumor%20Incidence%20of%20the%20Pten-Deficient%20Mice" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237&title=Tumor%20Spectrum%2C%20Tumor%20Latency%20and%20Tumor%20Incidence%20of%20the%20Pten-Deficient%20Mice&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237&amp;title=Tumor%20Spectrum%2C%20Tumor%20Latency%20and%20Tumor%20Incidence%20of%20the%20Pten-Deficient%20Mice" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001237&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001237';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Tumor%20Spectrum%2C%20Tumor%20Latency%20and%20Tumor%20Incidence%20of%20the%20Pten-Deficient%20Mice http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001237" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001237" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">













          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Carcinogenesis%22" title="Search for articles in the subject area:'Carcinogenesis'"><div class="flagText">Carcinogenesis</div></a>
              <div data-categoryid="20019" data-articleid="25306"
                   data-categoryname="Carcinogenesis"
                   class="flagImage" title="Flag 'Carcinogenesis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Epithelium%22" title="Search for articles in the subject area:'Epithelium'"><div class="flagText">Epithelium</div></a>
              <div data-categoryid="48027" data-articleid="25306"
                   data-categoryname="Epithelium"
                   class="flagImage" title="Flag 'Epithelium' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Immunohistochemistry+techniques%22" title="Search for articles in the subject area:'Immunohistochemistry techniques'"><div class="flagText">Immunohistochemistry techniques</div></a>
              <div data-categoryid="32287" data-articleid="25306"
                   data-categoryname="Immunohistochemistry techniques"
                   class="flagImage" title="Flag 'Immunohistochemistry techniques' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Lymphomas%22" title="Search for articles in the subject area:'Lymphomas'"><div class="flagText">Lymphomas</div></a>
              <div data-categoryid="33151" data-articleid="25306"
                   data-categoryname="Lymphomas"
                   class="flagImage" title="Flag 'Lymphomas' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mouse+models%22" title="Search for articles in the subject area:'Mouse models'"><div class="flagText">Mouse models</div></a>
              <div data-categoryid="32069" data-articleid="25306"
                   data-categoryname="Mouse models"
                   class="flagImage" title="Flag 'Mouse models' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Prostate+cancer%22" title="Search for articles in the subject area:'Prostate cancer'"><div class="flagText">Prostate cancer</div></a>
              <div data-categoryid="19371" data-articleid="25306"
                   data-categoryname="Prostate cancer"
                   class="flagImage" title="Flag 'Prostate cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Prostate+gland%22" title="Search for articles in the subject area:'Prostate gland'"><div class="flagText">Prostate gland</div></a>
              <div data-categoryid="49021" data-articleid="25306"
                   data-categoryname="Prostate gland"
                   class="flagImage" title="Flag 'Prostate gland' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Squamous+cell+carcinomas%22" title="Search for articles in the subject area:'Squamous cell carcinomas'"><div class="flagText">Squamous cell carcinomas</div></a>
              <div data-categoryid="25459" data-articleid="25306"
                   data-categoryname="Squamous cell carcinomas"
                   class="flagImage" title="Flag 'Squamous cell carcinomas' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=5067'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=1206'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=6339&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=14311">Correct the dose of LY294002</a><br>Posted by chunming_chen</p>
      <p><a href="/annotation/listThread.action?root=6655">Correct the dose of 4-OHT</a><br>Posted by chunming_chen</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
